Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions

By  

Current Medicinal Chemistry, Vol. 19, Iss. 11, 2012-04 ,pp. : 1587-1601

Bentham Science Publishers

Access to resources Recommend Favorite

Selective A2a receptor agonists as inhibitors of cellular activation

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 723-728

Informa Healthcare

Access to resources Recommend Favorite

Molecular and pharmacological characterization of the murine tachykinin NK 3 receptor

By Sarau H.M.   Feild J.A.   Ames R.S.   Foley J.J.   Nuthulaganti P.   Schmidt D.B.   Buckley P.T.   Elshourbagy N.A.   Brawner M.E.   Luttmann M.A.   Giardina G.A.M.   Hay D.W.P.  

European Journal of Pharmacology, Vol. 413, Iss. 2, 2001-02 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite

Tachykinin NK 3 receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways

By Daoui S.   Ahnaou A.   Naline E.   Emonds-Alt X.   Lagente V.   Advenier C.  

European Journal of Pharmacology, Vol. 433, Iss. 2, 2001-12 ,pp. : 199-207

Elsevier

Access to resources Recommend Favorite

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice

By Teixeira R.M.   Santos A.R.S.   Ribeiro S.J.   Calixto J.B.   Rae G.A.   De Lima T.C.M.  

European Journal of Pharmacology, Vol. 311, Iss. 1, 1996-09 ,pp. : 7-14

Elsevier

Access to resources Recommend Favorite